BillionaireNet
Prasad
G.V. Prasad
Rank #2354
INDIAHealthcarePharmaceuticals

G.V. Prasad

Net Worth
$1.583B
+0.58% (24h)
G.V. Prasad, a prominent figure in the global pharmaceutical industry, is the Co-Chairman and Managing Director of Dr. Reddy's Laboratories. With a net worth of $1.58 billion as of December 2025, his wealth stems primarily from his visionary leadership and strategic contributions to the company. Prasad's career spans over two decades, marked by pivotal achievements in shaping Dr. Reddy's into a leading generics powerhouse. Educated in chemical engineering and holding an MBA, Prasad is recognized for his innovative approach, commitment to ethical practices, and significant contributions to philanthropy.

The Full Dossier

Early Life and Education

G.V. Prasad was born in Nellore, Andhra Pradesh, India, in 1960. He received his early education in Hyderabad and Nellore. He pursued a Bachelor of Science in Engineering from the Illinois Institute of Technology and a Master's degree in Industrial Administration from Purdue University.

Rise to Success

Prasad's career in the pharmaceutical industry began when he co-founded Benzex Labs in 1985, which was later acquired by Dr. Reddy's Laboratories. In 1990, he became the CEO and MD of Cheminor Drugs Ltd. In 2001, Cheminor Drugs merged with Dr. Reddy's Laboratories, and Prasad became the Vice-Chairman and CEO, playing a crucial role in the company's global expansion and generics strategy. Under his leadership, Dr. Reddy's Laboratories has transformed into a global pharmaceutical giant.

Key Business Strategies

Prasad is recognized for his emphasis on innovation, ethical practices, and strategic global alliances. He has spearheaded initiatives to expand the company's global footprint, particularly in regulated markets. His focus on research and development has been instrumental in the launch of new drug formulations and the development of patient-centric therapies.

Philanthropy

G.V. Prasad is actively involved in philanthropy, focusing on causes such as healthcare access and education for underprivileged children. He supports organizations like the Dr. Reddy's Foundation, the Akshaya Patra Foundation, and the T. T. Reddy Foundation, contributing to initiatives that drive social impact and community development.

Career Timeline

2025

Reappointed as Co-Chairman and Managing Director

Reappointed to the role for a five-year term beginning January 2026.

2015

India Business Leader of the Year

Recognized as India Business Leader of the Year by CNBC Asia.

2014

India's Best CEO

Declared India's Best CEO in the Large Company category by Business Today.

2001

Vice-Chairman and CEO of Dr. Reddy's Laboratories

Became the Vice-Chairman and CEO of Dr. Reddy's Laboratories after the merger with Cheminor Drugs.

1990

CEO and MD of Cheminor Drugs Ltd

Served as CEO and Managing Director of Cheminor Drugs Ltd.

1985

Co-founded Benzex Labs

Co-founded Benzex Labs, a pharmaceutical enterprise. The company was later acquired by Dr. Reddy's Laboratories.

Philanthropic Impact

Healthcare and Social CausesUndisclosed

Dr. Reddy's Foundation

Supports community service and cultural promotion

Poverty AlleviationUndisclosed

Acumen Fund

Supports a non-profit venture that uses entrepreneurial approaches to eliminate global poverty.

Environmental ConservationUndisclosed

WWF-India

Supports conservation efforts.

Wealth Trajectory